Children born prematurely may develop a characteristic retinal disease named retinopathy of prematurity (ROP). This disease could lead to retinal detachment and blindness. ROP was traditionally treated with laser, but injection with a medication (A-VEGF) has become more common.
In this study, the researchers will explore whether treatment of ROP affects visual function and retinal development. To explore this, the study group will examine children with ROP (but not treated) with children treated with either laser or injection. The researchers will compare the children's visual functions (e.g. visual acuity and visual field) and their retinas (e.g. central and peripheral retina).
Patients treated for ROP with either laser or injection of A-VEGF.
Patients previously diagnosed with ROP but not treated for the condition.
Age below six years at date of examination.
A developmental level not compatible with performing the study examinations.
Patients born or treated outside Norway
Known ocular or systemic disease that can give structural or functional changes in the retina.